The DOI matches its Crossref record; 21 of the 21 references it cites were found in a registry or an index.
Hypertension with or without adrenal hyperplasia due to different inherited mutations in the potassium channel KCNJ5
Open accessAbstract
We recently implicated two recurrent somatic mutations in an adrenal potassium channel, KCNJ5, as a cause of aldosterone-producing adrenal adenomas (APAs) and one inherited KCNJ5 mutation in a Mendelian form of early severe hypertension with massive adrenal hyperplasia. The mutations identified all altered the channel selectivity filter, producing increased Na + conductance and membrane depolarization, the signal for aldosterone production and proliferation of adrenal glomerulosa cells. We report herein members of four kindreds with early onset primary aldosteronism of unknown cause. Sequencing of KCNJ5 revealed that affected members of two kindreds had KCNJ5 G151R mutations, identical to one of the prevalent recurrent mutations in APAs. These individuals had severe progressive aldosteronism and hyperplasia requiring bilateral adrenalectomy in childhood for blood pressure control. Affected members of the other two kindreds had KCNJ5 G151E mutations, which are not seen in APAs. These subjects had easily controlled hypertension and no evidence of hyperplasia. Surprisingly, electrophysiology of channels expressed in 293T cells demonstrated that KCNJ5 G151E was the more extreme mutation, producing a much larger Na + conductance than KCNJ5 G151R , resulting in rapid Na + -dependent cell lethality. We infer that this increased lethality limits adrenocortical cell mass and the severity of aldosteronism in vivo, accounting for the milder phenotype among these patients. These findings demonstrate striking variations in phenotypes and clinical outcome resulting from different mutations of the same amino acid in KCNJ5 and have implications for the diagnosis and pathogenesis of primary aldosteronism with and without adrenal hyperplasia.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Chobanian, A. V. (2003) · JAMA · doi:10.1001/jama.289.19.2560 · Cited by 25,386
Global burden of hypertension: analysis of worldwide data
Kearney, P. M., Whelton, M., Reynolds, K., Muntner, P., Whelton, P. K., & He, J. (2005) · The Lancet · doi:10.1016/s0140-6736(05)17741-1 · Cited by 8,594
The Structure of the Potassium Channel: Molecular Basis of K + Conduction and Selectivity
Doyle, D. A., Cabral, J. M., Pfuetzner, R. A., Kuo, A., Gulbis, J. M., Cohen, S. L., Chait, B. T., & MacKinnon, R. (1998) · Science · doi:10.1126/science.280.5360.69 · Cited by 6,807
(1976) · Medical Journal of Australia · doi:10.5694/j.1326-5377.1976.tb115280.x · Cited by 5,237
Molecular Mechanisms of Human Hypertension
Lifton, R. P., Gharavi, A. G., & Geller, D. S. (2001) · Cell · doi:10.1016/s0092-8674(01)00241-0 · Cited by 1,686 · cited 1×
“Mutations in genes resulting in increased net salt reabsorption markedly raise blood pressure, whereas those that reduce salt reabsorption can cause life-threatening low blood pressure (5, 6).”
Self-citationA prospective study of the prevalence of primary aldosteronism in 1,125 hypertensive patients
Rossi, G. P., Bernini, G., Caliumi, C., Desideri, G., Fabris, B., Ferri, C., Ganzaroli, C., Giacchetti, G., Letizia, C., Maccario, M., et al. (2006) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2006.07.059 · Cited by 1,467
Lifton, R. P., Dluhy, R. G., Powers, M., Rich, G. M., Cook, S., Ulick, S., & Lalouel, J.-M. (1992) · Nature · doi:10.1038/355262a0 · Cited by 1,158
Self-citationK + Channel Mutations in Adrenal Aldosterone-Producing Adenomas and Hereditary Hypertension
Choi, M., Scholl, U. I., Yue, P., Björklund, P., Zhao, B., Nelson-Williams, C., Ji, W., Cho, Y., Patel, A., Men, C. J., et al. (2011) · Science · doi:10.1126/science.1198785 · Cited by 1,004
Self-citationKrapivinsky, G., Gordon, E. A., Wickman, K., Velimirović, B., Krapivinsky, L., & Clapham, D. E. (1995) · Nature · doi:10.1038/374135a0 · Cited by 847
Mutations in the K+ channel signature sequence
Heginbotham, L., Lu, Z., Abramson, T., & MacKinnon, R. (1994) · Biophysical Journal · doi:10.1016/s0006-3495(94)80887-2 · Cited by 830
Sinha, I. P. (2012) · Seminars in Fetal and Neonatal Medicine · doi:10.1016/j.siny.2012.09.006 · Cited by 707
OMURA, M., SAITO, J., YAMAGUCHI, K., KAKUTA, Y., & NISHIKAWA, T. (2004) · Hypertension Research · doi:10.1291/hypres.27.193 · Cited by 562
A novel form of human mendelian hypertension featuring nonglucocorticoid-remediable aldosteronism
Geller, D. S., Zhang, J., Wisgerhof, M. V., Shackleton, C., Kashgarian, M., & Lifton, R. P. (2008) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2008-0594 · Cited by 296 · cited 2×
“Whether the observed differential response to mineralocorticoid antagonists is fully explained by differences in aldosterone levels at young age is unclear; mineralocorticoids other than aldosterone, such as 18-oxocortisol, are produced in patients with the T158Amutation (17), and differential production of these unme…”
BackgroundInfluentialSelf-citationGrowth, including Reproduction and Morphological Development.
Altman, P. L., & Dittmer, D. S. (1962) · Zenodo (CERN European Organization for Nuclear Research) · doi:10.5281/zenodo.10733202 · Cited by 262
Recent Trends in the Prevalence of High Blood Pressure and its Treatment and Control, 1999-2008
Yoon, S. S., Ostchega, Y., & Louis, T. (2010) · PsycEXTRA Dataset · doi:10.1037/e665602010-001 · Cited by 155
Czirják, G., Fischer, T., Spät, A., Lesage, F., & Enyedi, P. (2000) · Molecular Endocrinology · doi:10.1210/mend.14.6.0466 · Cited by 155
Genetic dissection of human blood pressure variation: common pathways from rare phenotypes.
Lifton, R. P. (2004) · PubMed · Cited by 88
Self-citationPRIMARY ALDOSTERONISM: CLINICAL STAFF CONFERENCE AT THE NATIONAL INSTITUTES OF HEALTH
Bartter, F. C., & Biglieri, E. G. (1958) · Annals of Internal Medicine · doi:10.7326/0003-4819-48-3-647 · Cited by 84
An ACTH- and ATP-regulated Background K+ Channel in Adrenocortical Cells Is TREK-1
Enyeart, J. J., Xu, L., Danthi, S. J., & Enyeart, J. A. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m207233200 · Cited by 83
Adrenocortical stem and progenitor cells: Unifying model of two proposed origins
Wood, M. A., & Hammer, G. D. (2010) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2010.11.012 · Cited by 75
Familial Hyperaldosteronism, Not Suppressed by Dexamethasone*
Greco, R. G., CARROLL, J. E., Morris, D. J., Grekin, R. J., & Melby, J. C. (1982) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-55-5-1013 · Cited by 29
Self-citation
Cited by
Flynn, J. T., Kaelber, D. C., Baker-Smith, C. M., Blowey, D., Carroll, A. E., Daniels, S. R., de Ferranti, S. D., Dionne, J. M., Falkner, B., Flinn, S. K., et al. (2017) · Pediatrics · doi:10.1542/peds.2017-1904 · Cited by 3,651
Funder, J. W., Carey, R. M., Mantero, F., Murad, M. H., Reincke, M., Shibata, H., Stowasser, M., & Young, W. F. (2016) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2015-4061 · Cited by 2,925
Hypertension: Renin–Angiotensin–Aldosterone System Alterations
te Riet, L., van Esch, J. H. M., Roks, A. J. M., van den Meiracker, A. H., & Danser, A. H. J. (2015) · Circulation Research · doi:10.1161/circresaha.116.303587 · Cited by 706
Poulter, N. R., Prabhakaran, D., & Caulfield, M. (2015) · The Lancet · doi:10.1016/s0140-6736(14)61468-9 · Cited by 672
Scholl, U. I., Goh, G., Stölting, G., de Oliveira, R. C., Choi, M., Overton, J. D., Fonseca, A. L., Korah, R., Starker, L. F., Kunstman, J. W., et al. (2013) · Nature Genetics · doi:10.1038/ng.2695 · Cited by 627
Self-citation
Metadata
- Authors
- Scholl, U. I., Nelson-Williams, C., Yue, P., Grekin, R., Wyatt, R. J., Dillon, M. J., Couch, R., Hammer, L. K., Harley, F. L., Farhi, A., Wang, W.-H., & Lifton, R. P.
- Venue
- Proceedings of the National Academy of Sciences
- Published
- 2012-01-30
- Volume
- 109
- Issue
- 7
- Pages
- 2533-2538
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- OpenAlex
- W1991449126
- Cited by
- 259
- References
- 21
- FWCI
- 22.78
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.